Try our beta test site

Video/Audio Distraction Analgesia for Simulated Oncology Procedure Pain

This study has been completed.
Sponsor:
Collaborators:
National Institutes of Health (NIH)
Seattle Cancer and Aging Program
Information provided by (Responsible Party):
Chris Hoffer, University of Washington
ClinicalTrials.gov Identifier:
NCT00701571
First received: June 17, 2008
Last updated: September 12, 2011
Last verified: September 2011
  Purpose
The purpose of this study is to compare the analgesic efficacy of three different types of video/audio distraction in normal volunteers subjected to carefully controlled and non-injurious thermal pain delivered to the skin of the lower back, simulating discomfort of a lumbar puncture. Two of the distraction techniques include immersive virtual reality (VR). The most efficacious distraction technique will be used in a subsequent clinical study in cancer patients.

Condition Intervention
Pain
Procedure: Virtual Reality distraction

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Double Blind (Subject, Investigator)
Primary Purpose: Treatment
Official Title: Video/Audio Distraction Analgesia for Simulated Oncology Procedure Pain

Further study details as provided by University of Washington:

Primary Outcome Measures:
  • To compare positional techniques and differing types of VR presentation (immersive vs. low tech). We will also compare age cohorts (18-21, 40-60, and older than 60 years). [ Time Frame: upon completion of data collection ]

Estimated Enrollment: 180
Study Start Date: September 2005
Study Completion Date: December 2009
Primary Completion Date: December 2009 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: 1
3 cohorts: 18-21 years, 40-60 years, and older than 60 years
Procedure: Virtual Reality distraction
Virtual Reality involves the participant wearing a helmet with sight and sound. the visual provided is a type of immersive video game, the game used is "Snow World". In some cases the participant will be exposed to 3D representation of the game, and in other cases a lower tech version with less immersive qualities.

  Eligibility

Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • healthy men and women
  • 18-21y, 40-60y, or older than 60y

Exclusion Criteria:

  • a predisposition to motion sickness
  • unusual sensitivity or lack of sensitivity to pain
  • chronic pain
  • peripheral neuropathy
  • sensitive skin
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00701571

Locations
United States, Washington
University of Washington
Seattle, Washington, United States, 98195
Sponsors and Collaborators
University of Washington
National Institutes of Health (NIH)
Seattle Cancer and Aging Program
Investigators
Principal Investigator: Samuel R Sharar, MD University of Washington
  More Information

Responsible Party: Chris Hoffer, Research Coordinator, University of Washington
ClinicalTrials.gov Identifier: NCT00701571     History of Changes
Other Study ID Numbers: 26745
1R21CA107256-01A1 ( US NIH Grant/Contract Award Number )
P20CA103728-04 ( US NIH Grant/Contract Award Number )
Study First Received: June 17, 2008
Last Updated: September 12, 2011

Keywords provided by University of Washington:
Virtual Reality
Oncology
Lumbar puncture

ClinicalTrials.gov processed this record on March 24, 2017